DARE

Conviction 53HealthcareScan · Thu, Jun 25, 2026

DARE$2.02-2.88%

ResistanceSupportVol 14

Vol MA14 187.94K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Dare Bioscience, Inc.PHARMACEUTICAL PREPARATIONSwww.darebioscience.com ↗

Price2.02

Change-2.88%

Gap+1.44%

Rel volume0.82×

Avg volume187.79K

Avg $ vol387.35K

SMA 202.07

SMA 502.32

SMA 2001.99

Price vs 50-12.95%

Price vs 200+1.55%

MA stackmixed

50/200 cross—

Supertrenddown · 2.55

RSI (14)45

MACD hist0.01

MACD crossbull · 5d

Stoch %K / %D47 / 55

ADX (14)9

+DI / −DI17 / 16

RSI divergence—

MACD divergence—

ATR %+8.90%

ADR %7.04%

52w high3.27

52w low1.30

From 52w high-38.23%

Above 52w low+55.38%

New 52w highNo

SqueezeOn · 4d

Bollinger width21.21%

%B0.39

Donchian pos36.17%

Donchian high2.32

Donchian low1.85

AVWAP (52w high)3.75

vs AVWAP high-46.15%

AVWAP (52w low)2.65

vs AVWAP low-23.64%

OBV trendDown

Chaikin MF (20)-0.20

Today vs 20d0.82×

Avg vol (14d)187.94K

Avg vol (20d)187.79K

Avg $ vol (20d)387.35K

Market cap30.26M

RS 3m (vs SPY)+40.68%

RS 6m (vs SPY)-8.21%

RS line new highNo

Trend template4/8

Technical rank30.4

1 week-2.88%

1 month-13.68%

3 months+44.29%

6 months-6.48%

1 year-24.34%

YTD+3.59%

P/E-2.26

P/B41.20

P/S29.37

P/FCF-2.95

EPS-1.20

Div yield—

ROE—

ROA-48.15%

Debt/Eq0.01

Current1.03

EV/EBITDA-0.99

Gross margin—

Net margin—

Rev growth—

EPS growth-230.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value11.75M

Revenue152.46K

Net income-3M

Gross profit—

Free cash flow-10.27M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out14.98M

Employees24

ListedThu, Apr 10, 2014

Free float13.52M

Float %94.6%

Short interest824.91K

Days to cover2.6d

Short volume52.2%

Squeeze score33 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank30.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.44

Support1.85

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DARE

All disclosures →

No recent disclosed trades by Congress in DARE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DARE

No recent insider (Form 4) filings in DARE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DARE · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.